The FDA recall affects more than 25,000 of the Fridley-run company’s devices and follows reports of 17 injuries.

Twenty-eight years later, as a political science professor emeritus at Stanford, Krehbiel just became the first person in the ...

The BrainSense Adaptive technology is designed for use with Medtronic’s Percept PC and RC deep brain neurostimulators. The Percept RC implant, which received FDA approval in January 2024 ...

Shortly after obtaining a greenlight in Europe and after more than 10 years in development, Medtronic has now received the FDA’s approval for its adaptive, closed-loop neurostimulation approach ...

Capstan Medical, a startup focused on robotic-assisted mitral and tricuspid valve replacement, recently completed its first ...

BrainSense™ Adaptive DBS is available to Medtronic DBS patients with Parkinson's who have been implanted with a Percept™ neurostimulator, as well as future Medtronic DBS patients. With more ...

The brain implants market is projected to grow from US$ 7.21 billion in 2022 to US$ 17.65 billion by 2030, at a CAGR of 11.8% ...

In 2022, the brain implants market was valued at over USD 5.7 billion, and its rapid expansion is fueled by several key factors. One of the most significant drivers is the rising incidence of nervous ...

Medtronic plc (NYSE:MDT – Get Free Report) has received a consensus rating of “Hold” from the sixteen ratings firms that are ...

From new partnerships to product launches, here are 12 key developments in orthobiologics during the first quarter of 2025. 1. Medtronic and Kuros Biosciences signed a strategic agreement to support ...